At a Churchill Club event in Mountain View, Calif., venture capitalist Steve Jurvetson touts the latest advancements in the development of artificial life–ones he believes will soon engender “biotech 2.0.”
At a Churchill Club event in Mountain View, Calif., venture capitalist Steve Jurvetson touts the latest advancements in the development of artificial life–ones he believes will soon engender “biotech 2.0.”
Start your week smarter with our weekly e-mail newsletter. It's your cheat sheet for good ideas. Get it.
Editor-in-Chief
Larry Dignan is editor-in-chief of SmartPlanet and ZDNet. He is also editorial director of TechRepublic. Previously, he was an editor at eWeek, Baseline and CNET News. He has written for WallStreetWeek.com, Inter@ctive Week, New York Times and Financial Planning. He holds degrees from the Columbia University Graduate School of Journalism and the University of Delaware. He is based in New York but resides in Pennsylvania.